{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T22:49:57Z","timestamp":1773010197690,"version":"3.50.1"},"reference-count":55,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2010,5,3]],"date-time":"2010-05-03T00:00:00Z","timestamp":1272844800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2010,5,3]],"date-time":"2010-05-03T00:00:00Z","timestamp":1272844800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["British J Pharmacology"],"published-print":{"date-parts":[[2010,8]]},"abstract":"<jats:p>\n                    <jats:bold>BACKGROUND AND PURPOSE<\/jats:bold>\n                    Dexmedetomidine, an \u03b1\n                    <jats:sub>2<\/jats:sub>\n                    \u2010adrenoceptor agonist, exhibits anti\u2010nociceptive actions at the spinal cord and enhances the effect of local anaesthetics in the peripheral nervous system. Although the latter action may be attributed in part to inhibition of nerve conduction produced by dexmedetomidine, this has not been fully examined yet.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>EXPERIMENTAL APPROACH<\/jats:bold>\n                    We examined the effects of various adrenoceptor agonists including dexmedetomidine, and tetracaine, a local anaesthetic, on compound action potentials (CAPs) recorded from the frog sciatic nerve, using the air\u2010gap method.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>KEY RESULTS<\/jats:bold>\n                    Dexmedetomidine reversibly and concentration\u2010dependently reduced the peak amplitude of CAPs (IC\n                    <jats:sub>50<\/jats:sub>\n                    = 0.40\u2003mmol\u00b7L\n                    <jats:sup>\u22121<\/jats:sup>\n                    ). This action was not antagonized by two \u03b1\n                    <jats:sub>2<\/jats:sub>\n                    \u2010adrenoceptor antagonists, yohimbine and atipamezole; the latter antagonist itself reduced CAP peak amplitude. Clonidine and oxymetazoline, two other \u03b1\n                    <jats:sub>2<\/jats:sub>\n                    \u2010adrenoceptor agonists, also inhibited CAPs; the maximum effect of clonidine was only 20%, while oxymetazoline was less potent (IC\n                    <jats:sub>50<\/jats:sub>\n                    = 1.5\u2003mmol\u00b7L\n                    <jats:sup>\u22121<\/jats:sup>\n                    ) than dexmedetomidine. On the other hand, (\u00b1)\u2010adrenaline, (\u00b1)\u2010noradrenaline, \u03b1\n                    <jats:sub>1<\/jats:sub>\n                    \u2010adrenoceptor agonist (\u2010)\u2010phenylephrine and \u03b2\u2010adrenoceptor agonist (\u2010)\u2010isoprenaline (each 1\u2003mmol\u00b7L\n                    <jats:sup>\u22121<\/jats:sup>\n                    ) had no effect on CAPs. Tetracaine reversibly reduced CAP peak amplitude (IC\n                    <jats:sub>50<\/jats:sub>\n                    of 0.014\u2003mmol\u00b7L\n                    <jats:sup>\u22121<\/jats:sup>\n                    ).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>CONCLUSIONS AND IMPLICATIONS<\/jats:bold>\n                    Dexmedetomidine reduced CAP peak amplitude without \u03b1\n                    <jats:sub>2<\/jats:sub>\n                    \u2010adrenoceptor activation (at concentrations &gt;1000\u2010fold higher than those used as \u03b1\n                    <jats:sub>2<\/jats:sub>\n                    adrenoceptor agonist), with a lower potency than tetracaine. CAPs were inhibited by other \u03b1\n                    <jats:sub>2<\/jats:sub>\n                    adrenoceptor agonists, oxymetazoline and clonidine, and also an \u03b1\n                    <jats:sub>2<\/jats:sub>\n                    adrenoceptor antagonist atipamezole. Thus, some drugs acting on \u03b1\n                    <jats:sub>2<\/jats:sub>\n                    adrenoceptors are able to block nerve conduction.\n                  <\/jats:p>","DOI":"10.1111\/j.1476-5381.2010.00833.x","type":"journal-article","created":{"date-parts":[[2010,5,4]],"date-time":"2010-05-04T02:51:31Z","timestamp":1272941491000},"page":"1662-1676","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":74,"title":["High concentrations of dexmedetomidine inhibit compound action potentials in frog sciatic nerves without \u03b1\n                    <sub>2<\/sub>\n                    adrenoceptor activation"],"prefix":"10.1111","volume":"160","author":[{"given":"Toshifumi","family":"Kosugi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kotaro","family":"Mizuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsugumi","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikio","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiichi","family":"Kumamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,5,3]]},"reference":[{"issue":"1","key":"e_1_2_7_2_1","first-page":"S1","article-title":"Guide to Receptors and Channels (GRAC), 4th edn","volume":"158","author":"Alexander SPH","year":"2009","journal-title":"Br J Pharmacol"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200059020-00012"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1213\/00000539-199810000-00026"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e318182c26b"},{"key":"e_1_2_7_6_1","first-page":"295","article-title":"The \u03b12\u2010adrenergic agonists clonidine and guanfacine produce tonic and phasic block of conduction in rat sciatic nerve fibers","volume":"76","author":"Butterworth JF","year":"1993","journal-title":"Anesth Analg"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0031-6997(25)06780-8"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1211\/jpp.57.11.0006"},{"key":"e_1_2_7_9_1","first-page":"369","volume-title":"Goodman & Gilman's The Pharmacological Basis of Therapeutics","author":"Catterall WA","year":"2006"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aep107"},{"key":"e_1_2_7_11_1","first-page":"134","article-title":"Vasoconstrictors in spinal anesthesia with tetracaine \u2013 a comparison of epinephrine and phenylephrine","volume":"63","author":"Concepcion M","year":"1984","journal-title":"Anesth Analg"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199206000-00013"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199211000-00024"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e318164ca81"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-4598(200102)24:2<254::AID-MUS110>3.0.CO;2-#"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2003.11.039"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(97)01118-7"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200008000-00016"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199609000-00026"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0361-9230(99)00057-X"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199409000-00011"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(91)90046-S"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1213\/00000539-199205000-00017"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-198012000-00006"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.2008.06260.x"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199710000-00032"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200011000-00030"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-6576.2006.00919.x"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0706868"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200303000-00016"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2044.1999.00659.x"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-6147(97)90625-8"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000539-200112000-00056"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-198711000-00061"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1213\/01.ANE.0000100680.77978.66"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2008.06.002"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0265021507000543"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1152\/jn.00575.2001"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(96)00224-5"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(91)90535-X"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-198812000-00004"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.anes.0000281916.65365.4e"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1213\/00000539-199611000-00025"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(92)90615-B"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1954.tb01344.x"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2885.2007.00931.x"},{"key":"e_1_2_7_47_1","first-page":"291","article-title":"Adrenergic neuron blockade by clonidine: comparison with guanethidine and local anesthetics","volume":"195","author":"Starke K","year":"1972","journal-title":"Arch Int Pharmacodyn"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(92)90617-D"},{"key":"e_1_2_7_49_1","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0022-3565(25)20276-2","article-title":"Relative efficacy of spinal alpha\u20102 agonists, dexmedetomidine, clonidine and ST\u201091, determined in vivo by using N\u2010ethoxycarbonyl\u20102\u2010ethoxy\u20101,2\u2010dihydroquinoline, an irreversible antagonist","volume":"258","author":"Takano Y","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_7_50_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000539-199807000-00023"},{"key":"e_1_2_7_51_1","doi-asserted-by":"publisher","DOI":"10.1213\/00000539-198607000-00014"},{"key":"e_1_2_7_52_1","first-page":"29","article-title":"Pharmacological profiles of medetomidine and its antagonist, atipamezole","volume":"85","author":"Virtanen R","year":"1989","journal-title":"Acta Vet Scand"},{"key":"e_1_2_7_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(88)90744-3"},{"key":"e_1_2_7_54_1","first-page":"237","volume-title":"Goodman & Gilman's The Pharmacological Basis of Therapeutics","author":"Westfall TC","year":"2006"},{"key":"e_1_2_7_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(85)90537-4"},{"key":"e_1_2_7_56_1","doi-asserted-by":"publisher","DOI":"10.1213\/ane.0b013e318176be73"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1476-5381.2010.00833.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1476-5381.2010.00833.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/j.1476-5381.2010.00833.x","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1476-5381.2010.00833.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T21:07:51Z","timestamp":1773004071000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1476-5381.2010.00833.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,3]]},"references-count":55,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["10.1111\/j.1476-5381.2010.00833.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1476-5381.2010.00833.x","archive":["Portico"],"relation":{},"ISSN":["0007-1188","1476-5381"],"issn-type":[{"value":"0007-1188","type":"print"},{"value":"1476-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,3]]},"assertion":[{"value":"2010-05-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}